CareTech AI acquired by small cap company

Blue Cloud Softech Solutions Ltd’s stock is in focus after the company’s board members gave in-principle approval for the 100% acquisition of CareTech AI Group. The acquisition will be done through a share swap, where the company will make a preferential allotment of its equity shares.

The Target Group, which includes CareTech AI Inc. and its wholly-owned subsidiaries CareCareer Tech LLC and Envision NJ LLC, is a US-based AI-driven healthcare tech and services company. CareCareer Tech LLC operates an AI-enabled healthcare workforce platform in the US, while Envision NJ LLC provides enterprise automation and orchestration solutions.

According to the Target Group’s management, the company’s consolidated revenue for 2025 was around $80.2 million. For the seven months ended July 31, 2026, the revenue was around $67.7 million, with an estimated revenue of $116 million for the full calendar year 2026. However, these numbers are based on the Target Group’s management estimates and will be independently verified during the due diligence process.

The acquisition is expected to be completed through a share swap, with the company issuing new shares to the Target Group’s shareholders. The exact terms of the acquisition, including the number of shares to be issued and the swap ratio, have not been disclosed.

Blue Cloud Softech’s stock price rose 1.69% to $23.40 on the BSE at 9:20 am, following the announcement.

In a recent development, the company announced that it had started delivering services under the Master Services Agreement (MSA) with SpaceX International Ltd, MY. The first work order under this agreement has a contract value of $150 million, with $70 million allocated for AI infrastructure, cybersecurity, telecommunications, and data center solutions.

The company expects to start delivering and billing for this project from the current quarter.

It will be important to monitor the integration process and the potential benefits between the two companies. The acquisition is expected to be completed in the coming months, subject to regulatory approvals and other conditions.